OTCMKTS:BIOGY BioGaia AB (publ) (BIOGY) Stock Price, News & Analysis $10.81 0.00 (0.00%) As of 04/25/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHeadlinesSEC FilingsShort InterestBuy This Stock About BioGaia AB (publ) Stock (OTCMKTS:BIOGY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BioGaia AB (publ) alerts:Sign Up Key Stats Today's Range$10.81▼$10.8150-Day Range$9.35▼$10.8152-Week Range$9.35▼$10.81Volume25,000 shsAverage Volume500 shsMarket CapitalizationN/AP/E Ratio2.57Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewBioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was founded in 1990 and is based in Stockholm, Sweden.Read More… Receive BIOGY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioGaia AB (publ) and its competitors with MarketBeat's FREE daily newsletter. Email Address BIOGY Stock News HeadlinesEuropean Dividend Stocks To Watch NowApril 2, 2025 | finance.yahoo.com3 Dividend Stocks To Consider With Up To 5.1% YieldFebruary 19, 2025 | finance.yahoo.comFrom Social Security to Social Prosperity?In less than a decade, Social Security could be out of money. But a surprising plan from Trump’s inner circle may not just save the system — it could unlock a major opportunity for savvy investors. Financial insider Jim Rickards calls it “Social Prosperity,” and says those who act now could see the biggest gains.April 26, 2025 | Paradigm Press (Ad)Unveiling Three Undiscovered Gems with Strong FoundationsJanuary 31, 2025 | finance.yahoo.comHigh Growth Tech And 2 Other Promising Stocks For Your PortfolioJanuary 20, 2025 | finance.yahoo.comBioGaia And 2 Other Swedish Dividend Stocks To Enhance Your PortfolioOctober 28, 2024 | uk.finance.yahoo.comBioGaia AB: BioGaia's preliminary results for the third quarter did not reach market expectationsOctober 24, 2024 | finanznachrichten.deHigh Growth Tech Stocks In Sweden October 2024October 23, 2024 | finance.yahoo.comSee More Headlines BIOGY Stock Analysis - Frequently Asked Questions How have BIOGY shares performed this year? BioGaia AB (publ)'s stock was trading at $10.00 at the beginning of the year. Since then, BIOGY shares have increased by 8.1% and is now trading at $10.81. View the best growth stocks for 2025 here. When did BioGaia AB (publ)'s stock split? Shares of BioGaia AB (publ) split on Thursday, May 26th 2022. The 2.5-1 split was announced on Thursday, May 26th 2022. The newly minted shares were issued to shareholders after the closing bell on Thursday, May 26th 2022. An investor that had 100 shares of stock prior to the split would have 250 shares after the split. How do I buy shares of BioGaia AB (publ)? Shares of BIOGY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today4/26/2025Next Earnings (Estimated)5/05/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:BIOGY CIK1572957 Webwww.biogaia.com Phone(685) 552-9300FaxN/AEmployees200Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio2.57 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report This page (OTCMKTS:BIOGY) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredDeepSeek’s Clear and Present DangerDeepSeek — the alleged “$5.5 million” AI project — isn’t an open-source breakthrough. It’s a Trojan horse.Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioGaia AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share BioGaia AB (publ) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.